文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

非创伤患者大量输血方案的系统评价与Meta分析

Massive transfusion protocols in nontrauma patients: A systematic review and meta-analysis.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论在非创伤大量出血成人中,实施大量输血方案对24小时死亡率无显著影响,对1个月死亡率有降低趋势但未达统计学显著,证据有限。

该系统评价与Meta分析检索PubMed,纳入12项2007至2017年发表的回顾性研究、共2475例非创伤大量出血成人患者,比较按大量输血方案(MTP)输血与未按方案输血。最常见的大量输血指征为围手术期、产科、胃肠道出血及血管急症。5项比较输血制品数量的研究中4项显示MTP组与非MTP组无显著差异。Meta分析显示MTP对24小时死亡率无显著影响(OR 0.42,95%CI 0.01-16.62,P=0.65),对1个月死亡率有降低趋势但未达统计学显著(OR 0.56,95%CI 0.30-1.07,P=0.08)。作者认为证据有限,MTP可能与非创伤患者死亡率降低相关,但研究间患者特征及MTP指征与定义高度异质,需进一步前瞻性研究。

要点

  • 12项回顾性研究共2475例非创伤大量出血成人,MTP对24小时死亡率无显著影响(OR 0.42,95%CI 0.01-16.62,P=0.65)。
  • MTP对1个月死亡率有降低趋势但未达统计学显著(OR 0.56,95%CI 0.30-1.07,P=0.08)。
  • 5项比较输血制品数量的研究中4项显示MTP组与非MTP组无显著差异。
  • 非创伤患者大量输血最常见指征为围手术期、产科、胃肠道出血及血管急症。
  • 作者认为证据有限,MTP可能与非创伤患者死亡率降低相关,但研究间患者特征及MTP指征与定义高度异质,需进一步前瞻性研究。

适用人群与场景

  • 非创伤大量出血、年龄18岁及以上的成人患者。
  • 研究纳入英文原始研究论文,评估非创伤患者中的大量输血方案。

研究设计与关键结果

  • 研究类型为系统评价与Meta分析,检索PubMed,筛选252篇摘要,最终纳入12项2007至2017年发表的回顾性研究,共2475例患者。
  • 纳入研究人群各异,大量输血最常见指征为围手术期、产科、胃肠道出血及血管急症。
  • 5项比较MTP组与非MTP组输血制品数量的研究中,4项显示无显著差异。
  • Meta分析(Mantel-Haenszel随机效应模型)显示MTP对24小时死亡率无显著影响(OR 0.42,95%CI 0.01-16.62,P=0.65)。
  • Meta分析显示MTP对1个月死亡率有降低趋势但未达统计学显著(OR 0.56,95%CI 0.30-1.07,P=0.08)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,证据等级为level III。
  • 局限:纳入研究患者人群异质,各研究中的MTP方案异质。
  • 作者结论:证据有限,MTP可能与非创伤患者死亡率降低相关,但患者特征及MTP指征与定义高度异质,需进一步前瞻性研究。

对床旁实践的改变

  • 作者认为,在非创伤大量出血成人中实施MTP可能与死亡率降低相关,但现有证据有限,患者特征及MTP指征与定义高度异质。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Massive bleeding is a major cause of death both in trauma and nontrauma patients. In trauma patients, the implementation of massive transfusion protocols (MTP) led to improved outcomes. However, the majority of patients with massive bleeding are nontrauma patients.

OBJECTIVES: To assess if the implementation of MTP in nontrauma patients with massive bleeding leads to improved survival.

DATA SOURCES: National Library of Medicine's Medline database (PubMed).

STUDY ELIGIBILITY CRITERIA: Original research articles in English language investigating MTP in nontrauma patients.

PARTICIPANTS: Nontrauma patients with massive bleeding 18 years or older.

INTERVENTION: Transfusion according to MTP versus off-protocol.

STUDY APPRAISAL AND SYNTHESIS METHODS: Systematic literature review using PubMed. Outcomes assessed were mortality and transfused blood products. Studies that compared mortality of MTP and non-MTP groups were included in meta-analysis using Mantel-Haenszel random effect models.

RESULTS: A total of 252 abstracts were screened. Of these, 12 studies published 2007 to 2017 were found to be relevant to the topic, including 2,475 patients. All studies were retrospective and comprised different patient populations. Most frequent indications for massive transfusion were perioperative, obstetrical and gastrointestinal bleeding, as well as vascular emergencies. Four of the five studies that compared the number of transfused blood products in MTP and non-MTP groups revealed no significant difference. Meta-analysis revealed no significant effect of MTP on the 24-hour mortality (odds ratio 0.42; 95% confidence interval 0.01-16.62; p = 0.65) and a trend toward lower 1-month mortality (odds ratio 0.56; 95% confidence interval 0.30-1.07; p = 0.08).

LIMITATIONS: Heterogeneous patient populations and MTP in the studies included.

CONCLUSION: There is limited evidence that the implementation of MTP may be associated with decreased mortality in nontrauma patients. However, patient characteristics, as well as the indication and definition of MTP were highly heterogeneous in the available studies. Further prospective investigation into this topic is warranted.

LEVEL OF EVIDENCE: Systematic review and meta-analysis, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Sommer N, Schnüriger B, Candinas D, et al. Massive transfusion protocols in nontrauma patients: A systematic review and meta-analysis. J Trauma Acute Care Surg. 2019. PMID: 30376535. doi:10.1097/TA.0000000000002101

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。